COVID-19 Monoclonal Antibody Treatment
Monoclonal Antibodies are produced in a laboratory to act as substitute antibodies to fight the COVID-19 virus. They have the ability to neutralize the virus and block the virus from attaching to the human cells; making it difficult for the virus to multiple and cause harm, giving you passive immunity.
Who is eligible for monoclonal antibody treatments?
Have recently tested positive for COVID-19
Experiencing mild to moderate symptoms
Are at high-risk for developing complications
Immunosuppressive Disease/Immunosuppressive Treatment